IL-10 ELISA Kit

Produktnummer ABIN625007

Produktdetails IL-10 ELISA Kit

Target: IL-10 (IL10) (Interleukin 10 (IL10))

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 1-150 pg/mL

Untere Nachweisgrenze: 1 pg/mL

Applikation: ELISA

Verwendungszweck: Human IL-10 ELISA Kit for cell culture supernatants, plasma, and serum samples.

Proben: Plasma, Cell Culture Supernatant, Serum

Analytische Methode: Quantitative

Spezifität: This ELISA kit shows no cross-reactivity with any of the cytokines tested: human BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-15, I-309, IP-10, G-CSF, GM-CSF, IFN-gamma, Leptin (OB), MCP-1, MCP-2, MCP-3, MDC, MIP-1 alpha, MIP-1 beta, MIP-1 delta, PARC, PDGF, RANTES, SCF, TARC, TGF-beta, TIMP-1, TIMP-2, TNF-alpha, TNF-beta, TPO, VEGF.

Sensitivität: < 1 pg/mL

Produktmerkmale:

• Strip plates and additional reagents allow for use in multiple experiments
• Quantitative protein detection
• Establishes normal range
• The best products for confirmation of antibody array data

Bestandteile:

• Pre-Coated 96-well Strip Microplate
• Wash Buffer
• Stop Solution
• Assay Diluent(s)
• Lyophilized Standard
• Biotinylated Detection Antibody
• Streptavidin-Conjugated HRP
• TMB One-Step Substrate

Benötigtes Material:

• Distilled or deionized water
• Precision pipettes to deliver 2 μL to 1 μL volumes
• Adjustable 1-25 μL pipettes for reagent preparation
• 100 μL and 1 liter graduated cylinders
• Tubes to prepare standard and sample dilutions
• Absorbent paper
• Microplate reader capable of measuring absorbance at 450nm
• Log-log graph paper or computer and software for ELISA data analysis

Anwendungsinformationen

Applikationshinweise: Recommended Dilution for serum and plasma samples2 fold

Probenmenge: 100 μL

Plattentyp: Pre-coated

Protokoll:

1. Prepare all reagents, samples and standards as instructed in the manual.
2. Add 100 μL of standard or sample to each well.
3. Incubate 2.5 h at RT or O/N at 4 °C.
4. Add 100 μL of prepared biotin antibody to each well.
5. Incubate 1 h at RT.
6. Add 100 μL of prepared Streptavidin solution to each well.
7. Incubate 45 min at RT.
8. Add 100 μL of TMB One-Step Substrate Reagent to each well.
9. Incubate 30 min at RT.
10. Add 50 μL of Stop Solution to each well.
11. Read at 450 nm immediately.

Aufbereitung der Reagenzien:

1. Bring all reagents and samples to room temperature (18-25 °C) before use.
   2. Sample dilution: If your samples need to be diluted, Assay Diluent A (Item D) should be used for dilution of serum/plasma samples. 1x Assay Diluent B (Item E) should be used for dilution of culture supernatants and urine. Suggested dilution for normal serum/plasma: 2 fold. Please note that levels of the target protein may vary between different specimens. Optimal dilution factors for each sample must be determined by the investigator.
   3. Assay Diluent B should be diluted 5-fold with deionized or distilled water.
   4. Preparation of standard: Briefly spin the vial of Item C and then add 400 µL Assay Diluent A (for serum/plasma samples) or 1x Assay Diluent B (for cell culture medium and urine) into Item C vial to prepare a 22 ng/mL standard. Dissolve the powder thoroughly by a gentle mix. Add 5 µL IL-10 standard from the vial of Item C, into a tube with 728.3 µL Assay Diluent A or 1x Assay Diluent B to prepare a 150 pg/mL stock standard solution. Pipette 300 µL Assay Diluent A or 1x Assay Diluent B into each tube. Use the stock standard solution to produce a dilution series . Mix each tube thoroughly before the next transfer. Assay Diluent A or 1x Assay Diluent B serves as the zero standard (0 pg/mL). 5 µL standard + 728.3 µL 300 µL 300 µL 300 µL 300 µL 300 µL 300myl 150 75 37.5 18.75 9.38 4.69 2.34 0 pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL
   5. If the Wash Concentrate (20x) (Item B) contains visible crystals, warm to room temperature and mix gently until dissolved. Dilute 20 ml of Wash Buffer Concentrate into deionized or distilled water to yield 400 ml of 1x Wash Buffer.
   6. Briefly spin the Detection Antibody vial (Item F) before use. Add 100 µL of 1x Assay Diluent B into the vial to prepare a detection antibody concentrate. Pipette up and down to mix gently (the concentrate can be stored at 4 °C for 5 days). The detection antibody concentrate should be diluted 80-fold with 1x Assay Diluent B and used in step 4 of Part VI Assay Procedure.
   7. Briefly spin the HRP-Streptavidin concentrate vial (Item G) and pipette up and down to mix gently before use. HRP-Streptavidin concentrate should be diluted 200-fold with 1x Assay Diluent B. For example: Briefly spin the vial (Item G) and pipette up and down to mix gently . Add 50 µL of HRP-Streptavidin concentrate into a tube with 10 ml 1x Assay Diluent B to prepare a final 200 fold diluted HRP-Streptavidin solution (don't store the diluted solution for next day use). Mix well.

Testdurchführung:

1. Bring all reagents and samples to room temperature (18 - 25 °C) before use. It is recommended that all standards and samples be run at least in duplicate.
   2. Add 100 µL of each standard (see Reagent Preparation step 2) and sample into appropriate wells. Cover well and incubate for 2.5 hours at room temperature or over night at 4 °C with gentle shaking.
   3. Discard the solution and wash 4 times with 1x Wash Solution. Wash by filling each well with Wash Buffer (300 myl) using a multi-channel Pipette or autowasher. Complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining Wash Buffer by aspirating or decanting. Invert the plate and blot it against clean paper towels.
   4. Add 100 µL of 1x prepared biotinylated antibody (Reagent Preparation step 6) to each well. Incubate for 1 hour at room temperature with gentle shaking.
   5. Discard the solution. Repeat the wash as in step
   6. Add 100 µL of prepared Streptavidin solution (see Reagent Preparation step 7) to each well. Incubate for 45 minutes at room temperature with gentle shaking.
   7. Discard the solution. Repeat the wash as in step
   8. Add 100 µL of TMB One-Step Substrate Reagent (Item H) to each well. Incubate for 30 minutes at room temperature in the dark with gentle shaking.
   9. Add 50 µL of Stop Solution (Item I) to each well. Read at 450 nm immediately.

Ergebnisberechnung:

Calculate the mean absorbance for each set of duplicate standards, controls and samples, and subtract the average zero standard optical density. Plot the standard curve on log-log graph paper or using Sigma plot software, with standard concentration on the x-axis and absorbance on the y-axis. Draw the best-fit straight line through the standard points.
Typical Data: These standard curves are for demonstration only. A standard curve must be run with each assay. Assay Diluent A IL-10 concentration (pg/mL) O D =4 50 n m 0.1 1 10 0 1 10 100 Assay Diluent B IL-10 concentration (pg/mL) O D =4 50 n m 0.1 1 10 0 1 10 100
Sensitivity: The minimum detectable dose of IL-10 is typically less than 1 pg/mL.
Recovery: Recovery was determined by spiking various levels of recombinant human IL-10 into human serum, plasma and cell culture media. Mean recoveries are as follows: Sample Type Average % Recovery Range ( %) Serum 101.94 87-108 Plasma 102.39 93-109 Cell culture media 98.37 87-110
Linearity: a :2 Average % of Expected 97 95 98 1 2 . REPRODUCIBILITY tra-Assay: CV<10 %

Testpräzision: Intra-Assay: CV< 10 % Inter-Assay: CV< 12 %

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Handhabung: Avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: The entire kit may be stored at -20°C for up to 1 year from the date of shipment. Avoid repeated freeze-thaw cycles. The kit may be stored at 4°C for up to 6 months. For extended storage, it is recommended to store at -80°C.

Haltbarkeit: 6 months

Referenzen für IL-10 ELISA Kit (ABIN625007)

Yiu, Chan, Li, Tsang, Verdolini Abbott, Kwong, Ma, Tse, Lin: "Wound-healing effect of acupuncture for treating phonotraumatic vocal pathologies: A cytokine study." in: The Laryngoscope, Vol. 126, Issue 1, pp. E18-22, (2016) (PubMed).

Koob, Lim, Zabek, Massee: "Cytokines in single layer amnion allografts compared to multilayer amnion/chorion allografts for wound healing." in: Journal of biomedical materials research. Part B, Applied biomaterials, Vol. 103, Issue 5, pp. 1133-40, (2015) (PubMed).

Zeng, Xiang, Lin, Zhang, Liu, Kong, Gao, Lu, Wu, Yi, Zhong, Xu: "Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis." in: International journal of clinical and experimental pathology, Vol. 8, Issue 2, pp. 1341-53, (2015) (PubMed).

Mankad, Dupuis, Smile, Roberts, Brian, Lui, Genore, Zaghloul, Iaboni, Marcon, Anagnostou: "A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism." in: Molecular autism, Vol. 6, pp. 18, (2015) (PubMed).

Romanets-Korbut, Kovalevska, Seya, Sidorenko, Horvat: "Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response." in: Cellular & molecular immunology, Vol. 13, Issue 6, pp. 828-838, (2015) (PubMed).

Raeiszadeh Jahromi, Mahesh, Jayaraj, Holla, Vishweswaraiah, Ramachandra: "IL-10 and IL-17F Promoter Single Nucleotide Polymorphism and Asthma: A Case-Control Study in South India." in: Lung, Vol. 193, Issue 5, pp. 739-47, (2015) (PubMed).

Odewumi, Latinwo, Sinclair, Badisa, Abdullah, Badisa: "Effect of cadmium on the expression levels of interleukin-1α and interleukin-10 cytokines in human lung cells." in: Molecular medicine reports, Vol. 12, Issue 5, pp. 6422-6, (2015) (PubMed).

Liu, Liao, Zhao, Wu, Yung, Chan, Yoshimura, Lu: "Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications." in: European journal of immunology, Vol. 45, Issue 9, pp. 2683-93, (2015) (PubMed).

Santarelli, Gonnella, Di Giovenale, Cuomo, Capobianchi, Granato, Gentile, Faggioni, Cirone: "STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells." in: Scientific reports, Vol. 4, pp. 4241, (2014) (PubMed).

Gao, Ding, Xiao, Li, Chen, Zhou, Wang, Wu, Shi: "Anti-inflammatory and anti-apoptotic effect of combined treatment with methylprednisolone and amniotic membrane mesenchymal stem cells after spinal cord injury in rats." in: Neurochemical research, Vol. 39, Issue 8, pp. 1544-52, (2014) (PubMed).

Wang, He, Tang, Zhang: "Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10." in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, Vol. 113, Issue 2, pp. 204-8, (2014) (PubMed).

Attia, Abdallah, El-Khateeb, Saad, Lotfi, Abdallah, El-Shennawy: "Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines." in: Archives of dermatological research, Vol. 306, Issue 9, pp. 793-801, (2014) (PubMed).

Chen, Li, Xie, Huang, Yuan, Zeng: "IL-6, IL-10 and IL-13 are associated with pathogenesis in children with Enterovirus 71 infection." in: International journal of clinical and experimental medicine, Vol. 7, Issue 9, pp. 2718-23, (2014) (PubMed).

Liou, Shih, Chung, Chen: "Comparison of the effect of intensive versus conventional insulinotherapy in patients with cardiac surgery after cardiopulmonary bypass." in: The Chinese journal of physiology, Vol. 56, Issue 2, pp. 101-9, (2013) (PubMed).

Rocher, Singla: "SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages." in: PLoS ONE, Vol. 8, Issue 12, pp. e84009, (2013) (PubMed).

Chen, Shen, Jiang, Jun, Zhu, Chen, Liu: "Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients." in: Clinical and experimental medicine, Vol. 13, Issue 2, pp. 135-42, (2013) (PubMed).

Rocher, Singla, Singal, Parthasarathy, Singla: "Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages." in: Canadian journal of physiology and pharmacology, Vol. 90, Issue 7, pp. 947-51, (2013) (PubMed).

Garufi, Pistritto, Ceci, Di Renzo, Santarelli, Faggioni, Cirone, DOrazi: "Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation." in: PLoS ONE, Vol. 7, Issue 11, pp. e48342, (2012) (PubMed).

Wang, Williams, Krishnan, Liao, Liu, Mao, Shi, Mobley, Woodruff, Cleeland: "Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy." in: Brain, behavior, and immunity, Vol. 26, Issue 5, pp. 699-705, (2012) (PubMed).

Youssef, Elshal, Abo Elazem: "Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis." in: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, Vol. 23, Issue 2, pp. 267-73, (2012) (PubMed).

Details zu IL-10

Target: IL-10 (IL10) (Interleukin 10 (IL10))

Andere Bezeichnung: IL-10 (IL10 Produkte)

Synonyme: CSIF ELISA Kit, GVHDS ELISA Kit, IL-10 ELISA Kit, IL10A ELISA Kit, TGIF ELISA Kit, Il-10 ELISA Kit, IL10X ELISA Kit, interleukin 10 ELISA Kit, IL10 ELISA Kit, Il10 ELISA Kit

Hintergrund: Human IL-10 is produced by activated CD8 (+) peripheral blood T-cells, by T-helper CD4 (+) T-cell clones after both antigen-specific and polyclonal activation, by B-cell lymphomas, and by monocytes following cell activation by bacterial lipopolysaccharides and mast cells. IL-10 is a homodimeric protein with subunits having a length of 160 amino acids. Human IL-10 shows 73 percent amino acid homology with murine IL-10. IL-10 inhibits the synthesis of a number of cytokines such as IL-2 and TNF-beta in Th1 T-helper subpopulations of T-cells but not of Th2 T-helper cells. IL-10 also inhibits mitogen- or anti-CD3 induced proliferation of T-cells in the presence of accessory cells and reduces the production of IFN-gamma and IL-2. The Human IL-10 ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human IL-10 in serum, plasma, cell culture supernatants and urine. This assay employs an antibody specific for human IL-10 coated on a 96-well plate. Standards and samples are pipetted into the wells and IL-10 present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-human IL-10 antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of IL-10 bound. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm. Reproducibility: Intra-Assay: CV<10% Inter-Assay: CV<12%.

Gen-ID: 3586

UniProt: P22301

Pathways: Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints